Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2026)

Aquestive Therapeutics' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.27 for Q1 2026.

• In Q1 2026, Debt Ratio fell 16.86% year-over-year to 0.27; the TTM figure through Mar 2026 stood at 0.27 (down 16.86% YoY), while the FY2025 annual figure was 0.23, down 27.08% from the prior year.
• Debt Ratio was 0.27 for Q1 2026 at Aquestive Therapeutics, up from 0.23 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.02 in Q3 2022 to a low of 0.15 in Q2 2024.
• Historically, Debt Ratio has averaged 0.51 across 5 years, with a median of 0.37 in 2025.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio tumbled 78.34% in 2024, then jumped 151.16% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.91 in 2022, then slumped by 47.53% to 0.48 in 2023, then sank by 33.11% to 0.32 in 2024, then dropped by 27.08% to 0.23 in 2025, then rose by 17.45% to 0.27 in 2026.
• The last three Debt Ratio figures came in at 0.27 (Q1 2026), 0.23 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.